Adelene Perkins | CEO |
Dr. Claudio Dansky Ullmann | SVP, Clinical Development |
Larry Bloch | President |
Dr. Jeffery Kutok | Chief Scientific Officer |
Katherine Xu | William Blair |
Eric Joseph | JP Morgan |
Mike King | JMP Securities |
Yanan Zhu | Wells Fargo Securities |
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the Company’s Financial Results for the Fourth Quarter and Full Year 2017. My name is James and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow.